Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults

William Beau Mitchell, MD, Jennifer G. Davila, MD, Janine Keenan, RN, Jenai Jackson, Adit Tal, MD, Kerry A Morrone, MD, Ellen J Silver, PhD, Sarah H. O'Brien, MD, Deepa Manwani, MD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-138794

Published: 2020

Journal Articles

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic

Jennifer G. Davila, MD, W. Beau Mitchell, MD, Kerry A Morrone, MD, Ellen J Silver, PhD, Caterina P Minniti, MD, Henny H. Billett, MD MSc, Payal Desai, MD, Sarah H. O'Brien, MD, Deepa Manwani, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-137071

Published: 2020

Journal Articles

Prenatal Hemoglobinopathy Screening Practices: Areas for Improvement

Scott Moerdler, MD, Ellen Fraint, MD, Ellen Silver, PhD, Siobhan M Dolan, MD, M.P.H., Kafui A Demasio, MD, M.P.H., Michael E. Roth, MD, Deepa Manwani, MD, Kerry A Morrone, MD

Blood (2019) 134 (Supplement_1): 2298.

https://doi.org/10.1182/blood-2019-126084

Published: 2019

Journal Articles

An Intensive Transition Navigator Intervention Improves Transition Readiness to Adult Care in Youth with Sickle Cell Disease

Deepa Manwani, MD, Lynn Davidson, MD, Ellen Silver, Rosy Chhabra, PsyD, Caterina Minniti, MD, Deepa Rastogi, MD, Maya Doyle, LCSW-R, PhD, Kerry A Morrone, MD, Ruth Stein, MD, Suzette Oyeku, MD MPH, Laurie Bauman, PhD

Blood (2017) 130 (Supplement 1): 4634.

https://doi.org/10.1182/blood.V130.Suppl_1.4634.4634

Published: 2017

Journal Articles

Utilization of a Pediatric Sickle Cell Day Hospital By Patients with Sickle Cell Disease and Pain Events Is Associated with a Lower Rate of Inpatient Hospital Admission Compared to Utilization of the Pediatric Emergency Department

Rochelle Maxwell, MD, Veronika Polishchuk, MD, Jeremy Rosenblum, M. Catherine Driscoll, MD, Kerry A Morrone, MD, Jonathan B. Gill, MD, Michael E. Roth, MD, Deepa Manwani, MD

Blood (2017) 130 (Supplement 1): 4643.

https://doi.org/10.1182/blood.V130.Suppl_1.4643.4643

Published: 2017

Journal Articles

Decreased Hospital Readmissions for Vaso Occlusive Crisis with Implementation of a Sickle Cell Pain Action Plan (SPAP)

Kerry A Morrone, MD, Deepti Kalluri, MD, Jennifer G. Davila, MD, Gifty Edusei, PharmD, Basirat Shoberu, PharmD BCPPS, Janna Rosario, RN, Lisa M. Figueiredo, MD, Veronica P. Carullo, MD, Meagan Weiss, Michael Rinke, MD, Deepa Manwani, MD

Blood (2017) 130 (Supplement 1): 867.

https://doi.org/10.1182/blood.V130.Suppl_1.867.867

Published: 2017

Journal Articles

Efficacy of Dual Inhibition of p38 Mitogen Activated Protein Kinase (MAPK) and Tie-2 Kinase in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Blood (2014) 124 (21): 4628.

https://doi.org/10.1182/blood.V124.21.4628.4628

Published: 2014

Journal Articles

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Timothy Geoffrey Bowler, PhD MBBS, Matthias Bartenstein, MD, Kerry A. Morrone, MD, Mersedeh Rohanizadegan, MD, Rachel M. Kessel, MD, Lauren Hooda, Ishan Datt, Orsolya Giricz, PhD, Tushar D. Bhagat, PhD, Bartlomiej P Przychodzen, Simrit Parmar, Jonathan B. Gill, MD, Yiting Yu, PhD, Jaroslaw P. Maciejewski, MD PhD, Ulrich Steidl, MDPhD, Amit Verma, MD

Blood (2014) 124 (21): 4591.

https://doi.org/10.1182/blood.V124.21.4591.4591

Published: 2014

Journal Articles

Hydroxyurea Response in Pediatric Sickle Cell Disease Patients with Alpha Thalasssemia Trait

Lisa M. Figueiredo, MD, Kerry A. Morrone, MD, Catherine Wei, Hillel W Cohen, DrPH, MPH, Catherine Driscoll, MD, Deepa Manwani, MD

Blood (2014) 124 (21): 1377.

https://doi.org/10.1182/blood.V124.21.1377.1377

Published: 2014

Journal Articles

Association of Annexin A5 Resistance with Silent Infarct in Sickle Cell Disease

Kerry A. Morrone, MD, Xue Xiaonan, PhD, Suzette O. Oyeku, MD MPH, Jane A. Little, MD, Catherine Driscoll, MD, Jacob Rand, MD, Deepa Manwani, MD

Blood (2014) 124 (21): 1394.

https://doi.org/10.1182/blood.V124.21.1394.1394

Published: 2014

NARROW

Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic

Prenatal Hemoglobinopathy Screening Practices: Areas for Improvement

An Intensive Transition Navigator Intervention Improves Transition Readiness to Adult Care in Youth with Sickle Cell Disease

Utilization of a Pediatric Sickle Cell Day Hospital By Patients with Sickle Cell Disease and Pain Events Is Associated with a Lower Rate of Inpatient Hospital Admission Compared to Utilization of the Pediatric Emergency Department

Decreased Hospital Readmissions for Vaso Occlusive Crisis with Implementation of a Sickle Cell Pain Action Plan (SPAP)

Efficacy of Dual Inhibition of p38 Mitogen Activated Protein Kinase (MAPK) and Tie-2 Kinase in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Hydroxyurea Response in Pediatric Sickle Cell Disease Patients with Alpha Thalasssemia Trait

Association of Annexin A5 Resistance with Silent Infarct in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only